CLARK ESTATES INC/NY

Position in BIIB — Biogen Inc.

CIK 1056466 NEW YORK, NY

Position in BIIB

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$3,305,718

+$500,769 QoQ

Shares Held

15,300

0.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#294

of 1,036 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLARK ESTATES INC/NY holds $12,443,283 across 5 Drug Manufacturers - General names. BIIB ranks #1 (26.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BIIB	Biogen Inc. This page	15,300	$3,305,718
2	GILD	Gilead Sciences, Inc.	26,022	$3,287,619
3	BMY	Bristol Myers Squibb Co	43,000	$2,477,660
4	PFE	Pfizer Inc	96,750	$2,329,740
5	JNJ	Johnson & Johnson	4,105	$1,042,546

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,305,718	15,300	0.0%	Shares	Sole	2026-08-05
2026-03-31	$2,804,949	15,300	0.0%	Shares	Sole	2026-05-11
2025-12-31	$2,692,647	15,300	0.0%	Shares	Sole	2026-02-12
2025-09-30	$2,143,224	15,300	0.0%	Shares	Sole	2025-11-10
2025-06-30	$1,921,527	15,300	+29.7%	Shares	Sole	2025-08-11
2025-03-31	$1,614,164	11,796	-27.6%	Shares	Sole	2025-05-08
2024-12-31	$2,492,596	16,300	+0.9%	Shares	Sole	2025-02-06
2024-09-30	$3,130,516	16,150	+99.4%	Shares	Sole	2024-11-13
2021-09-30	$2,292,219	8,100	0.0%	Shares	Sole	2021-11-12
2021-06-30	$2,804,787	8,100	-58.7%	Shares	Sole	2021-08-10
2021-03-31	$5,483,100	19,600	+120.2%	Shares	Sole	2021-05-14
2020-12-31	$2,179,254	8,900	0.0%	Shares	Sole	2021-02-09
2020-09-30	$2,524,752	8,900	0.0%	Shares	Sole	2020-11-05
2020-06-30	$2,381,195	8,900	-34.1%	Shares	Sole	2020-08-05
2020-03-31	$4,271,130	13,500	—	Shares	Sole	2020-04-28
No filing history on record for this holder in this stock.